secwatch.observer — SEC 8-K summary
======================================

Issuer:     SUTRO BIOPHARMA, INC. (STRO)
CIK:        0001382101
Form:       8-K
Filed at:   2022-06-16T23:59:59+00:00
Accession:  0000950170-22-011712
Event type: other_material
Sentiment:  neutral
Materiality: 0.20
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Sutro Biopharma to present updated corporate presentation at JMP conference
---------------------------------------------------------------------------

- Corporate presentation attached as Exhibit 99.1, available on company website.
- Presentation covers company overview as of June 2022; no financial or pipeline data disclosed in filing.
- No material changes to business, guidance, or clinical programs announced in the 8-K.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1382101/000095017022011712/0000950170-22-011712-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1382101/000095017022011712/stro-20220616.htm
  HTML page:      https://secwatch.observer/filing/0000950170-22-011712

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer